Personalis Inc.

In News

Tempus move on Personalis (NASDAQ: PSNL) hinges on cancer tests and data from 50 million patients - Stock Titan

Stock Titan - Sep 15, 2026

Personalis, Inc. (PSNL) Stock Analysis: A Bold Bet in Cancer Genomics with a 30% Revenue Surge - DirectorsTalk Interviews

DirectorsTalk Interviews - Sep 18, 2026

Tempus to buy cancer test maker Personalis for $1.5 billion - Reuters

Reuters - Jul 20, 2026

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform - Business Wire

Business Wire - Jul 20, 2026

Tempus AI (TEM) Rallies As Upgrade, Earnings And Personalis Deal Align - timothysykes.com

timothysykes.com - Sep 15, 2026

Tempus to buy cancer test maker Personalis for $1.5B - MedTech Dive

MedTech Dive - Jul 20, 2026

Tempus AI to acquire Personalis for $1.5B - MobiHealthNews

MobiHealthNews - Jul 20, 2026

Latham & Watkins Advises Tempus AI on US$1.5 Billion Acquisition of Personalis - Latham & Watkins LLP

Latham & Watkins LLP - Jul 20, 2026

Tempus AI to Acquire Personalis in $1.5 Billion Deal, Deepening Its Foothold in Cancer Monitoring - oncodaily.com

oncodaily.com - Jul 27, 2026

Personalis Stock Price Forecast. Should You Buy PSNL? - StockInvest.us

StockInvest.us - Sep 11, 2026

Personalis Stock Is Up 250% in the Past Year. It Needs to Turn a Profit Next. - Yahoo Finance

Yahoo Finance - Aug 26, 2026

PSNL - Personalis Inc Stock Price and Quote - Finviz

Finviz - May 26, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment